Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
AIDS Research and Human Retroviruses
|
November 1, 1995
Low anticoagulant heparin retains anti-HIV type 1 activity in vitro
D R Coombe, H A Harrop, J Watton, et al.
Archives of Pathology & Laboratory Medicine
|
September 18, 1998
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban
M Laposata, D Green, E M Van Cott, et al.
Thrombosis and Haemostasis
|
April 1, 1995
Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity
E Gray, J Tubbs, S Thomas, et al.
Thrombosis Research
|
April 15, 1984
Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides
T W Barrowcliffe, R E Merton, S J Havercroft, et al.
American Journal of Clinical Pathology
|
May 16, 1998
Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on Anticoagulation
L Poller, T W Barrowcliffe, A M van den Besselaar, et al.
Thrombosis and Haemostasis
|
February 12, 1998
The European Concerted Action on Anticoagulation (ECAA) evaluation of a set of lyophilized normal plasmas to establish the normal prothrombin time for coagulometer systems
L Poller, T W Barrowcliffe, A M van den Besselaar, et al.
Thrombosis and Haemostasis
|
November 3, 1998
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisation
S Raut, M Di Giambattista, S A Bevan, et al.
Thrombosis and Haemostasis
|
December 1, 1996
European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins. Steering Committee
L Poller, T W Barrowcliffe, A M van den Besselaar, et al.
The Journal of Laboratory and Clinical Medicine
|
March 1, 1981
Factor VIII-related activities in therapeutic concentrates
T W Barrowcliffe, G Kemball-Cook, G Morris, et al.
Thrombosis Research
|
December 15, 1986
Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assays
A R Hubbard, A D Curtis, T W Barrowcliffe, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
AIDS Research and Human Retroviruses
|
November 1, 1995
Low anticoagulant heparin retains anti-HIV type 1 activity in vitro
D R Coombe, H A Harrop, J Watton, et al.
Archives of Pathology & Laboratory Medicine
|
September 18, 1998
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban
M Laposata, D Green, E M Van Cott, et al.
Thrombosis and Haemostasis
|
April 1, 1995
Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity
E Gray, J Tubbs, S Thomas, et al.
Thrombosis Research
|
April 15, 1984
Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides
T W Barrowcliffe, R E Merton, S J Havercroft, et al.
American Journal of Clinical Pathology
|
May 16, 1998
Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on Anticoagulation
L Poller, T W Barrowcliffe, A M van den Besselaar, et al.
Thrombosis and Haemostasis
|
February 12, 1998
The European Concerted Action on Anticoagulation (ECAA) evaluation of a set of lyophilized normal plasmas to establish the normal prothrombin time for coagulometer systems
L Poller, T W Barrowcliffe, A M van den Besselaar, et al.
Thrombosis and Haemostasis
|
November 3, 1998
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisation
S Raut, M Di Giambattista, S A Bevan, et al.
Thrombosis and Haemostasis
|
December 1, 1996
European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins. Steering Committee
L Poller, T W Barrowcliffe, A M van den Besselaar, et al.
The Journal of Laboratory and Clinical Medicine
|
March 1, 1981
Factor VIII-related activities in therapeutic concentrates
T W Barrowcliffe, G Kemball-Cook, G Morris, et al.
Thrombosis Research
|
December 15, 1986
Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assays
A R Hubbard, A D Curtis, T W Barrowcliffe, et al.
Page
of 16